slotkoers
Taipei Exchange
00:00:00 30-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
228
TWD
|
+0,66%
|
|
+2,70%
|
+11,76%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
2.582
|
4.368
|
4.384
|
4.499
|
7.407
|
11.110
|
Bedrijfswaarde
1 |
2.079
|
3.757
|
3.605
|
3.918
|
6.653
|
10.318
|
K/w-verhouding
|
34,4
x
|
43,6
x
|
18,4
x
|
18,3
x
|
13,9
x
|
17,8
x
|
Dividendrendement
|
2,53%
|
1,87%
|
2,48%
|
5,33%
|
6,99%
|
-
|
Marktkapitalisatie/omzet
|
8,49
x
|
7,35
x
|
5,12
x
|
4,34
x
|
5,29
x
|
6,58
x
|
Bedrijfswaarde/omzet
|
6,84
x
|
6,32
x
|
4,21
x
|
3,78
x
|
4,75
x
|
6,11
x
|
Bedrijfswaarde/EBITDA
|
29,8
x
|
20,6
x
|
10,4
x
|
9,86
x
|
8,31
x
|
11
x
|
Bedrijfswaarde/FCF
|
33,3
x
|
13,2
x
|
23,6
x
|
507
x
|
16,1
x
|
16,9
x
|
FCF Yield
|
3%
|
7,58%
|
4,24%
|
0,2%
|
6,2%
|
5,93%
|
Price to Book
|
3,98
x
|
6,45
x
|
4,93
x
|
4,4
x
|
5,59
x
|
7,79
x
|
Aantal aandelen (in duizenden)
|
54.463
|
54.463
|
54.463
|
54.463
|
54.463
|
54.463
|
Referentieprijs
2 |
47,40
|
80,20
|
80,50
|
82,60
|
136,0
|
204,0
|
Datum van publicatie
|
25/03/19
|
30/03/20
|
31/03/21
|
31/03/22
|
31/03/23
|
15/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
304,1
|
594,1
|
855,9
|
1.036
|
1.400
|
1.689
|
EBITDA
1 |
69,77
|
182,2
|
345,9
|
397,3
|
800,7
|
936,5
|
Bedrijfsresultaat (EBIT)
1 |
62,8
|
175,1
|
332,3
|
367,4
|
768
|
894,8
|
Operationele Marge
|
20,65%
|
29,46%
|
38,83%
|
35,47%
|
54,85%
|
52,98%
|
Resultaat voor belastingen (EBT)
1 |
87,38
|
154,4
|
337,8
|
357,5
|
777,2
|
909,4
|
Nettowinst (verlies)
1 |
74,66
|
100,4
|
238,1
|
245,6
|
533,8
|
625,7
|
Nettomarge
|
24,55%
|
16,91%
|
27,82%
|
23,72%
|
38,13%
|
37,05%
|
WPA
2 |
1,376
|
1,840
|
4,370
|
4,510
|
9,790
|
11,47
|
Free Cash Flow
1 |
62,36
|
284,6
|
152,8
|
7,729
|
412,5
|
612,1
|
FCF-marge
|
20,51%
|
47,9%
|
17,85%
|
0,75%
|
29,46%
|
36,24%
|
Kasstroomconversie (ebitda)
|
89,38%
|
156,21%
|
44,18%
|
1,95%
|
51,52%
|
65,36%
|
Kasstroomconversie (nettowinst)
|
83,53%
|
283,34%
|
64,18%
|
3,15%
|
77,28%
|
97,82%
|
Dividend per aandeel
2 |
1,200
|
1,500
|
2,000
|
4,400
|
9,500
|
-
|
Datum van publicatie
|
25/03/19
|
30/03/20
|
31/03/21
|
31/03/22
|
31/03/23
|
15/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
502
|
611
|
780
|
580
|
754
|
793
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
62,4
|
285
|
153
|
7,73
|
413
|
612
|
ROE (netto-inkomsten/eigen vermogen)
|
12,2%
|
15,2%
|
30,4%
|
25,7%
|
45,5%
|
45,5%
|
ROA (netto-inkomsten/totale activa)
|
5,53%
|
11,7%
|
16,8%
|
16,1%
|
29,3%
|
28,3%
|
Totale activa
1 |
1.349
|
858,7
|
1.420
|
1.524
|
1.822
|
2.211
|
Nettoactief per aandeel
2 |
11,90
|
12,40
|
16,30
|
18,80
|
24,30
|
26,20
|
Cashflow per aandeel
2 |
5,770
|
10,70
|
14,30
|
11,10
|
10,80
|
15,70
|
Capex
1 |
4,72
|
13,7
|
130
|
253
|
155
|
108
|
Capex/omzet
|
1,55%
|
2,3%
|
15,17%
|
24,43%
|
11,04%
|
6,37%
|
Datum van publicatie
|
25/03/19
|
30/03/20
|
31/03/21
|
31/03/22
|
31/03/23
|
15/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +11,76% | 381 mln. | | +26,28% | 42,68 mld. | | -3,99% | 42,4 mld. | | +45,32% | 40,04 mld. | | -6,20% | 28,31 mld. | | +6,36% | 24,94 mld. | | -21,47% | 18,96 mld. | | +27,58% | 12,3 mld. | | -2,75% | 11,95 mld. | | -2,02% | 11,55 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|